Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-10-23
2011-10-11
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S353000, C548S348100
Reexamination Certificate
active
08034813
ABSTRACT:
A brimonidine (5-bromo-6-(2-imidazolidinylideneamino)quinoxaline) pamoate polymorph exhibits characteristics disclosed herein. The brimonidine pamoate polymorph is included in a composition, device, or implant for use in the treatment or control of elevated intraocular pressure or in the neuroprotection of components of a neurological tissue to prevent progressive degeneration of such components. In particular, such a composition, device, or implant can be used to provide neuroprotection to cells and components of the optic nerve system.
REFERENCES:
patent: 4521210 (1985-06-01), Wong
patent: 4853224 (1989-08-01), Wong
patent: 4997652 (1991-03-01), Wong
patent: 5164188 (1992-11-01), Wong
patent: 5443505 (1995-08-01), Wong et al.
patent: 5501856 (1996-03-01), Ohtori et al.
patent: 5766242 (1998-06-01), Wong et al.
patent: 5824072 (1998-10-01), Wong
patent: 5869079 (1999-02-01), Wong et al.
patent: 6074661 (2000-06-01), Olejnik et al.
patent: 6194415 (2001-02-01), Wheeler et al.
patent: 6331313 (2001-12-01), Wong et al.
patent: 6369116 (2002-04-01), Wong et al.
patent: 6699493 (2004-03-01), Wong
patent: 2006/0257452 (2006-11-01), Hughes et al.
Danylkova et al., “Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy,” Exp Eye Res, 2007, (vol. 84), (p. 293-301).
Lafuente Lopez-Herrera et al., “Transient ischemia of the retina results in altered retrograde axoplasmic transport: neuroprotection with brimonidine,” Exp Neurology, 2002, (vol. 178), (p. 243-258).
Sweetman (Ed.), “Nonionic Surfactants,” Martindale the Complete Drug Reference, 2005, 34th ed., Pharma Press, (p. 1411-1416).
Davio Stephen R.
Hall Michael
McIntire Gregory L.
Suchit Shazad
Summersett Jon
Bausch & Lomb Incorporated
Vo Toan P.
Willis Douglas M
Wilson James O
LandOfFree
Polymorphs of brimonidine pamoate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphs of brimonidine pamoate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphs of brimonidine pamoate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4285828